Skip to main content
. 2012 Nov 21;18(43):6255–6262. doi: 10.3748/wjg.v18.i43.6255

Table 2.

Immunoglobulin A anti-tissue transglutaminase seropositivity in patients with liver disease and patients who underwent liver transplantation

IgA anti-tTG seropositivity Diagnosis M/F n (%)
Liver disease Wilson’s disease 1/3 4 (12.9)
Autoimmune hepatitis type I 1/4 5 (6.5)
Primary biliary cirrhosis 0/1 1 (3.1)
Budd-Chiari syndrome 0/1 1 (7.1)
Mild hepatic liver tests abnormalities 5/2 7 (20)
Liver steatosis 3/1 4 (3.3)
Viral hepatitis B 1/0 1 (0.9)
Toxic hepatitis 1/0 1 (4.8)
Nonalcoholic steatohepatitis 0/2 2 (8.7)
Primary sclerosing cholangitis 1/1 2 (3.4)
Polycystic liver 0/1 1 (10)
OLTx Wilson’s disease 1/1 2 (6.9)
Autoimmune hepatitis type I 0/2 2 (6.1)
Alcoholic liver cirrhosis 1/0 1 (0.6)

IgA: Immunoglobulin A; tTG: Tissue transglutaminase; OLTx: Patients who underwent liver transplantation; M/F: Male/female.